Oxurion/Investors/News/Oxurion NV Reports First Patient Dosed in Phase 2 study e…

Oxurion NV Reports First Patient Dosed in Phase 2 study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

1 Sep 2020General